Compare Qurate Retail Inc Series A (QVCAQ) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Qurate Retail Inc Series A vs UnitedHealth Group Inc — how do they compare? Qurate Retail Inc Series A trades at $0.04 (market cap $653.75K), while UnitedHealth Group Inc trades at $431 (market cap $396.27B). The key difference: UnitedHealth Group Inc is far larger — about 606149.1× Qurate Retail Inc Series A's market cap, and UnitedHealth Group Inc pays a 2.13% dividend while Qurate Retail Inc Series A pays none. Which is the better fit depends on your goals.
| QVCAQ | UNH | |
|---|---|---|
Market Cap | $653.75K | $396.27B |
Sector | Consumer Cyclical | Health |
52-Week High | $15.03 | $436.35 |
52-Week Low | $0.05 | $237.77 |
Enterprise Value | $4.73B | $442.96B |
Dividend Yield | — | 2.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QVCAQ trades at $0.0515, down 12.12% in the past 24 hours, with a bearish technical signal from moving averages. The company reported a net loss of $2.44 billion in 2025 on revenue of $9.23 billion, with negative profit margins and declining revenue trends. Cash flow improved due to financing activities, but negative equity and high debt-to-asset ratios of 77.57% highlight financial stress. Recent news includes QVC celebrating 40 years of live shopping innovation with a TikTok Shop Super Brand Day (PRNewsWire, May 28, 2026).
The outlook remains challenging due to persistent losses, high leverage, and revenue declines. Investment opportunities are limited given weak fundamentals, though low P/E and P/B ratios may attract value hunters. Key risks include bankruptcy concerns from negative equity, competitive pressures in retail, and inability to achieve profitability. Analyst sentiment is cautious, with no bullish indicators supporting near-term recovery.
UnitedHealth Group (UNH) trades at $421.55, down 1.07% on the day, with a bullish technical outlook supported by moving averages and ADX signals. The company reported strong Q2 2026 EPS of $6.38, beating estimates, and maintains robust cash flow generation. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns through dividends and buybacks.
UNH presents a favorable investment case with 82.7% analyst buy ratings and a $476.50 consensus price target, implying 13% upside. Risks include regulatory scrutiny from lawsuits and Medicaid fraud allegations, while demographic trends and operational efficiency support long-term growth. The stock's valuation at a P/E of 31.74 reflects premium pricing relative to historical margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Qurate Retail Inc Series A
Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, primarily using their televised shopping programs and via the Internet through their websites and mobile applications
Read more on QVCAQ →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
